Top Markets
Coin of the day
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA

FSNUY
株式のランク #183
Fresenius SE & Co. KGaA, a health care company, provides products and services... Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
株価
$12.65
時価総額
$114.00B
変化(1日)
1.36%
変化(1年)
3.52%
DE
取引 Fresenius SE & Co. KGaA (FSNUY)

カテゴリー

Fresenius SE & Co. KGaA(FSNUY)のP/E比率
July 2026 時点のP/E比率 TTM 15.42
Fresenius SE & Co. KGaA の最新の財務報告および株価によると、現在の P/E (TTM) は 15.42 です。2023 年末時点での P/E は -26.62 でした。
Fresenius SE & Co. KGaA の P/E 比率の履歴(2002 〜 2026)
各年末のP/E比率
P/E比率 変化
2026 (TTM) 15.42 -61.55%
2024 40.11 -250.69%
2023 -26.62 -347.86%
2022 10.74 -1.18%
2021 10.87 -12.06%
2020 12.36 -16.72%
2019 14.84 25.16%
2018 11.86 -40.46%
2017 19.91 -21.96%
2016 25.52 -3.60%
2015 26.47 20.88%
2014 21.90 10.82%
2013 19.76 21.32%
2012 16.29 85.50%
2011 8.78 4.03%
2010 8.44 19.22%
2009 7.08 -66.62%
2008 21.21 0.48%
2007 21.10 -10.70%
2006 23.63 253.85%
2005 6.68 10.06%
2004 6.07 -20.73%
2003 7.66 108.28%
2002 3.68 0.00%
類似企業や競合他社のP/E比率
企業 P/E比率 P/E比率の差
12.43 -19.39%
US
31.92 107.01%
SA
9.47 -38.57%
US
19.33 25.36%
CN
22.90 48.48%
US
P/E比率の読み方

株価収益率(P/E Ratio)は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の(0に近い)P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。